Management of Patients with Gestational Trophoblastic Neoplasia: Experience of the Southeastern Regional Center
Gestational trophoblastic neoplasia (GTN), a group of the more virulent malignant tumors in humans, is derived from the trophoblast of human pregnancy. Prior to 1956, the prognosis for these patients was exceedingly poor, regardless of the surgical or irradiation therapies utilized (1). Since that time and the advent of systemic chemotherapy as the primary therapeutic modality for these patients, results have become exceedingly good (2). Sequential reports have been published documenting increasingly good remission rates (3–6). Cure rates now approach 100% for patients without metastases and those with “good” prognosis metastatic disease. Even in patients with “poor” prognosis GTN, high rates of remission have been achieved with vigorous multi-modality therapy.
KeywordsHydatidiform Mole Gestational Trophoblastic Disease Trophoblastic Tumor Gestational Trophoblastic Neoplasia Invasive Mole
Unable to display preview. Download preview PDF.
- 1.Brewer, J. I., Halpern, B., and Torok, E. E., Gestational trophoblastic disease: selected clinical aspects and chorionic gonadotropin test methods, in: “Current Clinical Problems in Cancer,” R. C. Hickey, ed., Year Book Medical Publishers, Chicago (1979), p. 5.Google Scholar
- 2.Hammond, C. B., Weed, J. C., and Currie, J. L., The role of operation in current therapy of gestational trophoblastic disease, Amer. J. Obstet. Gynecol. 136: 844 (1980).Google Scholar
- 3.Li, M. D., Hertz, R., and Spencer, D. B., Effects of methotrexate upon choriocarcinoma and chorioadenoma, Proc. Soc. Exptl. Med. 93: 361 (1956).Google Scholar
- 4.Hertz, R., Lewis, J. L., Jr., and Lipsett, M. B., Five years’ experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women, Amer. J. Obstet. Gynecol. 82: 631 (1961).Google Scholar
- 5.Ross, G. T., Goldstein, D. P., Hertz, R., Lipsett, M. B., and Odell, W. D., Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in women, Amer. J. Obstet. Gynecol. 93: 223 (1965).Google Scholar
- 7.Brewer, J. I., Eckman, T. R., Dolkart, R. E., Toruk, E. E., and Webster, A., Gestational trophoblastic disease - a comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma, Amer. J. Obstet. Gynecol. 109: 335 (1971).Google Scholar
- 8.Bagshawe, K. D., Treatment of trophoblastic tumors, Ann. Acad. Med. 5: 273 (1976).Google Scholar
- 10.Vaitukaitis, J. L., Braunstein, G. D., and Ross, G. T., A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone, Amer. J. Obstet. Gynecol. 113: 751 (1972).Google Scholar
- 14.Smith, E. B., Weed, J. C., Tyrey, L., and Hammond, C. B., Treatment of nonmetastatic trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid, Amer. J. Obstet. Gynecol. 144: 88 (1982).Google Scholar
- 15.Maroulis, G. B., Hammond, C. B., Johnsrude, I. S., Weed, J. C., Jr., and Parker, R. T., Arteriography and infusional chemotherapy in localized trophoblastic disease, Obstet. Gynecol. 45: 397 (1945).Google Scholar
- 17.Einhorn, L. H. and Donohue, J. H., Cis-diamine dichloroplatinum, vinblastine, and bleomycin. Combination chemotherapy in disseminated testicular cancer, Ann. Intern. Med. 87: 293 (1967).Google Scholar
- 18.Newlands, E. S., The activity of epipodophyllis derivative VP 216–213, and cis-platinum in combination in drug resistant choriocarcinoma. International Symposium on Gestational Trophoblastic Tumors, London, May 1979.Google Scholar